TipRanks
Ultragenyx Pharmaceutical (MX:RARE)
:RARE
Mexico Market
RARE
Ultragenyx Pharmaceutical
RESEARCH TOOLSreports

Ultragenyx Pharmaceutical (RARE) Stock News & Sentiment

0 Followers
Ultragenyx Monetizes FDA Priority Review Voucher Asset
Premium
Company Announcements
Ultragenyx Monetizes FDA Priority Review Voucher Asset
9h ago
8K
RARE
Ultragenyx Launches 10-Year Gene Therapy Monitoring Program for MPS IIIA
Premium
Company Announcements
Ultragenyx Launches 10-Year Gene Therapy Monitoring Program for MPS IIIA
5d ago
RARE
Ultragenyx: FDA Gene Therapy Progress and Upcoming Pivotal Readouts Support Buy Rating with Unchanged $25 Price Target
Premium
Ratings
Ultragenyx: FDA Gene Therapy Progress and Upcoming Pivotal Readouts Support Buy Rating with Unchanged $25 Price Target
12d ago
RARE
Ultragenyx: Fayuvi Approval and Stronger Balance Sheet Support Hold Rating Amid Limited Near‑Term Catalysts
Premium
Ratings
Ultragenyx: Fayuvi Approval and Stronger Balance Sheet Support Hold Rating Amid Limited Near‑Term Catalysts
20d ago
RARE
Ultragenyx wins FDA approval for FAYUVI gene therapy
Premium
Company Announcements
Ultragenyx wins FDA approval for FAYUVI gene therapy
20d ago
8K
RARE
Red Cat, USA Rare Earth, uniQure, Ultragenyx, Copart Trending
Premium
Weekend Updates
Red Cat, USA Rare Earth, uniQure, Ultragenyx, Copart Trending
1M ago
CPRT
QURE
Ultragenyx Expands Rare Muscle Pipeline With First-in-Human UX016 Trial in GNE Myopathy
Premium
Company Announcements
Ultragenyx Expands Rare Muscle Pipeline With First-in-Human UX016 Trial in GNE Myopathy
1M ago
RARE
More MX:RARE News >

RARE News on the Web

FDA Approves Fayuvi. What Does It Mean for Ultragenyx (RARE)’s 2027 Profitability Target?
Insider Monkey
Bullish
Analysts Offer Insights on Healthcare Companies: Helus Pharma (HELP), Ultragenyx Pharmaceutical (RARE) and Novavax (NVAX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)
TipRanks News
Neutral
Ultragenyx confirms FDA approval of Fayuvi
TipRanks News
Bullish
FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A
TipRanks News
Bullish
Insider Move at Ultragenyx: Top Executive Executes Notable Stock Sale
TipRanks News
Neutral
Ultragenyx Pharmaceutical (RARE) Insider Sale: SVP, Chief Accounting Officer Theodore Huizenga ...
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)
TipRanks News
Bullish

News Score - Last 7 Days

Positive
MX:RARE
Sector Average
Media Buzz
This Week2 articles
Weekly Average16.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:RARE’s Media Buzz Sentiment?
2 articles about MX:RARE were published this week. In an average week, 16.75 articles are published.
    What is MX:RARE’s weekly average amount of articles?
    In an average week, 16.75 articles about MX:RARE are published.
      What is MX:RARE’s News Sentiment?
      100% of articles about MX:RARE were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        REGNRegeneron
        QTTBQ32 Bio
        NVSNovartis
        RHHVFRoche Holding AG
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week